Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2013 | 1 |
2014 | 6 |
2015 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Editorial overview: cancer genomics: kill it. Kill it dead.
Curr Opin Genet Dev. 2014 Feb;24:v-vi. doi: 10.1016/j.gde.2013.12.006. Epub 2014 Feb 23.
Curr Opin Genet Dev. 2014.
PMID: 24569083
No abstract available.
Inactivating CUX1 mutations promote tumorigenesis.
Wong CC, Martincorena I, Rust AG, Rashid M, Alifrangis C, Alexandrov LB, Tiffen JC, Kober C; Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium; Green AR, Massie CE, Nangalia J, Lempidaki S, Döhner H, Döhner K, Bray SJ, McDermott U, Papaemmanuil E, Campbell PJ, Adams DJ.
Wong CC, et al.
Nat Genet. 2014 Jan;46(1):33-8. doi: 10.1038/ng.2846. Epub 2013 Dec 8.
Nat Genet. 2014.
PMID: 24316979
Free PMC article.
Item in Clipboard
The evolving role of cancer cell line-based screens to define the impact of cancer genomes on drug response.
Garnett MJ, McDermott U.
Garnett MJ, et al.
Curr Opin Genet Dev. 2014 Feb;24(100):114-9. doi: 10.1016/j.gde.2013.12.002. Epub 2014 Mar 5.
Curr Opin Genet Dev. 2014.
PMID: 24607840
Free PMC article.
Review.
Item in Clipboard
Reading between the lines; understanding drug response in the post genomic era.
Alifrangis CC, McDermott U.
Alifrangis CC, et al.
Mol Oncol. 2014 Sep 12;8(6):1112-9. doi: 10.1016/j.molonc.2014.05.014. Epub 2014 Jun 10.
Mol Oncol. 2014.
PMID: 24957465
Free PMC article.
Review.
Item in Clipboard
Genome-wide chemical mutagenesis screens allow unbiased saturation of the cancer genome and identification of drug resistance mutations.
Brammeld JS, Petljak M, Martincorena I, Williams SP, Alonso LG, Dalmases A, Bellosillo B, Robles-Espinoza CD, Price S, Barthorpe S, Tarpey P, Alifrangis C, Bignell G, Vidal J, Young J, Stebbings L, Beal K, Stratton MR, Saez-Rodriguez J, Garnett M, Montagut C, Iorio F, McDermott U.
Brammeld JS, et al.
Genome Res. 2017 Apr;27(4):613-625. doi: 10.1101/gr.213546.116. Epub 2017 Feb 8.
Genome Res. 2017.
PMID: 28179366
Free PMC article.
Item in Clipboard
BRAF/NRAS wild-type melanoma, NF1 status and sensitivity to trametinib.
Ranzani M, Alifrangis C, Perna D, Dutton-Regester K, Pritchard A, Wong K, Rashid M, Robles-Espinoza CD, Hayward NK, McDermott U, Garnett M, Adams DJ.
Ranzani M, et al.
Pigment Cell Melanoma Res. 2015 Jan;28(1):117-9. doi: 10.1111/pcmr.12316. Epub 2014 Oct 13.
Pigment Cell Melanoma Res. 2015.
PMID: 25243813
Free PMC article.
No abstract available.
Item in Clipboard
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect.
Lopez-Serra P, Marcilla M, Villanueva A, Ramos-Fernandez A, Palau A, Leal L, Wahi JE, Setien-Baranda F, Szczesna K, Moutinho C, Martinez-Cardus A, Heyn H, Sandoval J, Puertas S, Vidal A, Sanjuan X, Martinez-Balibrea E, Viñals F, Perales JC, Bramsem JB, Ørntoft TF, Andersen CL, Tabernero J, McDermott U, Boxer MB, Vander Heiden MG, Albar JP, Esteller M.
Lopez-Serra P, et al.
Nat Commun. 2014 Apr 3;5:3608. doi: 10.1038/ncomms4608.
Nat Commun. 2014.
PMID: 24699711
Free PMC article.
Item in Clipboard
Cite
Cite